Hua Tuo Zai Zao Wan: A Family Stroke Remedy That Became a State Enterprise's Export Flagship

Disclaimer: This page is for historical and cultural education only and is not medical advice. References to traditional use describe what historical sources record or what is traditionally believed — not a claim that any product treats, cures, or prevents any disease. These statements have not been evaluated by the U.S. Food and Drug Administration or any other regulator. Consult a qualified physician with any health questions.

Hua Tuo Zai Zao Wan (华佗再造丸) traces to a family stroke remedy developed by physician Ran Xuefeng; his son, Ran Xiaofeng, donated the formula to the state in the 1980s — an account that appears consistently across multiple independent sources. The house's own telling adds that the Ran family had served as imperial physicians across five generations spanning more than 200 years; this site presents that lineage detail as the company's own account rather than independently verified history.

From a Qing-era apothecary to a modern pharmaceutical group

The house's corporate lineage runs from Qishengtang, founded in 1875, through a 1956 public–private partnership, the 1981 founding of the Guangzhou Qixing Pharmaceutical Factory, a 1993 restructuring with Hong Kong capital, and a 2012 renaming to Baiyunshan Qixing, the company's current name. Production of Hua Tuo Zai Zao Wan itself began in 1988.

This site did not find independent verification for a superlative claim, made by the company, that it was the first enterprise in the People's Republic to receive a patent for a state-level key research project — this page states the verified corporate timeline above without repeating that claim.

Baiyunshan Qixing holds China Time-Honored Brand recognition; this research was not able to independently confirm the specific date on which that recognition was granted, so this page does not state one. This site did not find evidence of an intangible-cultural-heritage listing for this house.

Hua Tuo Zai Zao Wan's formula is widely reported to hold protected, state-secret status in China, on evidence weaker than some of the other houses on this site — this page uses "widely reported" rather than a more confident phrasing to reflect that.

An export flagship, by the company's own account

Baiyunshan Qixing describes itself as an export leader in its product category for more than a decade, reaching, by its own account, 27 to 29 countries across six continents. This site presents that figure as the company's own statement, not an independently verified count. The company has also stated that it was among the first to receive permanent registration in Russia and import registration in South Korea for a stroke-focused Chinese medicine in its category — claims this page attributes explicitly to the company rather than presenting as independently confirmed firsts.

An official English-language website exists, but this research was not able to access its content, so this page states only that the English site exists.

A stroke-recovery positioning that travels well overseas

Across the overseas retail listings found in this research, Hua Tuo Zai Zao Wan is consistently marketed around traditional stroke-recovery use — more explicitly than most other houses covered on this site, where positioning is often broader. This is a real pattern in how the product is marketed to overseas buyers, not a clinical claim this site is making or endorsing — see the disclaimer above.

Markets: Vietnam and Indonesia

In Vietnam, "Hoa Đà Tái Tạo Hoàn" is a real, circulating translated name for the product. The company has stated that Hua Tuo Zai Zao Wan became, in 2003, the first traditional medicine from outside Vietnam added to that country's national health-insurance list — a claim corroborated across more than one round of this site's research but still resting on the company's own statement rather than an independently confirmed government record, and presented here on that basis.

In Indonesia, the product is available through several major e-commerce platforms and multiple independent sellers, consistently positioned around stroke recovery, as described above.